Business
Press Release Dec 01 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Zydus receives final approval from the USFDA forIvabradine Tablets, 5 mg and 7.5 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 01, 2023, titled \"Zydus receives final approval from the USFDA forIvabradine Tablets, 5 mg and 7.5 mg\". View Attachment","length":351,"tagName":"div"}]